New Research Validates Brain-Based Approach

Researchers at Peking University Sixth Hospital have published findings in Molecular Psychiatry showing that non-invasive neurostimulation technology can significantly improve attention scores and normalize brain activity patterns. The randomized, double-blind, sham-controlled trial followed 56 adults building focus skills over four weeks of treatment with Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) technology.

The active treatment group showed a 10.1-point average improvement on the Adult ADHD Self-Report Scale, compared to 5.5 points in the sham group—a statistically significant separation of 4.6 points (p < 0.001). Benefits emerged within the first two weeks and peaked at week four, with the approach proving well-tolerated and no serious adverse events reported.